Skip to main content

Nixon Peabody LLP

  • People
  • Capabilities
  • Insights
  • About
Trending Topics
    • People
    • Capabilities
    • Insights
    • About
    • Locations
    • Events
    • Careers
    • Alumni
    Practices

    View All

    • Affordable Housing
    • Community Development Finance
    • Corporate & Finance
    • Cybersecurity & Privacy
    • Entertainment & Media
    • Environmental
    • Franchising & Distribution
    • Government Investigations & White Collar Defense
    • Healthcare
    • Intellectual Property
    • International Services
    • Labor, Employment, and Benefits
    • Litigation
    • Private Wealth & Advisory
    • Project Finance
    • Public Finance
    • Real Estate
    • Regulatory & Government Relations
    Industries

    View All

    • Aviation
    • Cannabis
    • Consumer
    • Energy
    • Financial Services
    • Healthcare
    • Higher Education
    • Infrastructure
    • Manufacturing
    • Nonprofit Organizations
    • Real Estate
    • Sports & Stadiums
    • Technology
    Value-Added Services

    View All

    • Alternative Fee Arrangements

      Developing innovative pricing structures and alternative fee agreement models that deliver additional value for our clients.

    • Continuing Education

      Advancing professional knowledge and offering credits for attorneys, staff and other professionals.

    • Crisis Advisory

      Helping clients respond correctly when a crisis occurs.

    • DEI Strategic Services

      Providing our clients with legal, strategic, and practical advice to make transformational changes in their organizations.

    • eDiscovery

      Leveraging law and technology to deliver sound solutions.

    • Environmental, Social, and Governance (ESG)

      We help clients create positive return on investments in people, products, and the planet.

    • Global Services

      Delivering seamless service through partnerships across the globe.

    • Innovation

      Leveraging leading-edge technology to guide change and create seamless, collaborative experiences for clients and attorneys.

    • IPED

      Industry-leading conferences focused on affordable housing, tax credits, and more.

    • Legal Project Management

      Providing actionable information to support strategic decision-making.

    • Legally Green

      Teaming with clients to advance sustainable projects, mitigate the effects of climate change, and protect our planet.

    • Nixon Peabody Trust Company

      Offering a range of investment management and fiduciary services.

    • NP Capital Connector

      Bringing together companies and investors for tomorrow’s new deals.

    • NP Second Opinion

      Offering fresh insights on cases that are delayed, over budget, or off-target from the desired resolution.

    • NP Trial

      Courtroom-ready lawyers who can resolve disputes early on clients’ terms or prevail at trial before a judge or jury.

    • Social Impact

      Creating positive impact in our communities through increasing equity, access, and opportunity.

    • Women in Dealmaking

      We provide strategic counsel on complex corporate transactions and unite dynamic women in the dealmaking arena.

    1. Home
    2. Insights
    3. Alerts
    4. Illinois considers keeping doctors’ names off abortion pill prescription labels

      Alerts

    Alert / Healthcare

    Illinois considers keeping doctors’ names off abortion pill prescription labels

    Feb 19, 2025

    LinkedInX (Twitter)EmailCopy URL

    By Mambwe Mutanuka, Alexandra Busto, Rebecca Simone and Andrew Maglione

    Some states, Illinois being the latest, seek to bolster the scope of their shield laws for healthcare providers who prescribe abortion medications.

    What’s the impact?

    • Illinois is considering amending its existing shield law to mirror New York’s law allowing prescribers to request that pharmacies keep their names off prescription labels for abortion medications.
    • States considering shield law expansion must grapple with existing federal and state laws and regulations that mandate the inclusion of prescriber names on prescription labels.

    DOWNLOAD

    Keeping doctors’ names off abortion pill prescription labels (PDF)

    Following the US Supreme Court decision in Dobbs v. Jackson Women’s Health Organization, legal questions continue to arise about healthcare providers who prescribe abortion medications across state lines to patients in states with restrictive abortion laws. In response to the growing demand for telehealth reproductive health services, states such as New York, Massachusetts, Illinois, and California have enacted or proposed so-called “shield laws” to provide legal protections for these providers.

    In a move to further shield practitioners from legal risks, Illinois is considering amending its existing shield law to mirror New York’s recently enacted law[1] allowing prescribers to request that pharmacies keep their names off prescription labels for the abortion medications mifepristone and misoprostol.

    What is covered under the current Illinois shield law?

    Currently, the Illinois shield law:

    • Shields providers from foreign subpoenas, summons, or extraditions related to lawful reproductive care in Illinois;
    • Establishes a counterclaim for providers who have a judgment entered against them in another state for reproductive health care that is legal in Illinois; and
    • Prevents the Illinois Department of Financial and Professional Regulation (IDFPR) from taking action against practitioners based solely upon a person being disciplined in another state for providing or participating in any health care that is legal in Illinois.[2]

    Considerations for an enhanced shield law

    Illinois is considering bolstering its shield law in response to actions by Texas and Louisiana indicting a New York doctor for allegedly prescribing abortion pills across state borders. An amendment that would result in keeping prescribers’ names off abortion medications could have far-reaching consequences and is likely to face both legal and operational challenges regarding:

    • Conflicting rules under federal frameworks, such as those of the Federal Drug Administration;
    • Conflicting state law and state pharmacy board rules;
    • Medical liability and malpractice claims;
    • Informed consent and patient rights;
    • Fraud and prescription verification;
    • Pharmacy workflow and patient safety; and
    • Prescription transfers and refills.

    Because both federal and state laws and regulations typically mandate the inclusion of prescriber names on prescription labels, it remains to be seen how states like Illinois and New York can overcome the legal and operational obstacles that are sure to follow the enactment of such laws. In fact, New York’s governor, Kathy Hochul, is already working with legislators on a second bill that would ensure pharmacies cooperate with prescribers’ requests to keep their names off medication labels.

    Cross-border prescriptions—opportunities and risks

    The evolving legal framework for cross-border medication prescriptions presents both opportunities and risks for healthcare providers. While states enact or consider enacting further protections for reproductive health providers, such laws could have far-reaching implications for providers, as well as the pharmaceutical supply chain. Nixon Peabody will continue to monitor legislative and judicial developments related to cross-border abortion medication prescriptions.


    1. 2025 NY Assemb. Bill A2145A.
      [Back to reference]
    2. H.B. 4664, 103rd Gen. Assemb., Reg. Sess. (Il. 2023), codified at, e.g., 775 Ill. Comp. Stat. §§55/1-10, 55/1-20; 255 Ill. Comp. Stat. §60/22 (C).
      [Back to reference]

    Practices

    HealthcareHealthcare Regulatory & ComplianceFertility, Reproductive Medicine, Sexual Health & Wellness

    Industries

    Healthcare

    Insights And Happenings

    • Alert

      Connecticut seeks increased oversight of healthcare entity transactions

      Feb 21, 2025
    • Alert

      Illinois Antitrust Act amendments could impact healthcare transactions

      Feb 21, 2025
    • Article

      Projected changes to Medicaid under the new administration

      Feb 19, 2025
    The foregoing has been prepared for the general information of clients and friends of the firm. It is not meant to provide legal advice with respect to any specific matter and should not be acted upon without professional counsel. If you have any questions or require any further information regarding these or other related matters, please contact your regular Nixon Peabody LLP representative. This material may be considered advertising under certain rules of professional conduct.

    Subscribe to stay informed of the latest legal news, alerts, and business trends.Subscribe

    • People
    • Capabilities
    • Insights
    • About
    • Locations
    • Events
    • Careers
    • Alumni
    • Cookie Preferences
    • Privacy Policy
    • Terms of Use
    • Accessibility Statement
    • Statement of Client Rights
    • Purchase Order Terms & Conditions
    • Nixon Peabody International LLC
    • PAL
    © 2025 Nixon Peabody. All rights reserved